Logo image of ABO.BR

ABO GROUP ENVIRONMENT (ABO.BR) Stock Fundamental Analysis

EBR:ABO - Euronext Brussels - BE0974278104 - Common Stock - Currency: EUR

6.25  -0.05 (-0.79%)

Fundamental Rating

4

ABO gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 42 industry peers in the Commercial Services & Supplies industry. ABO has an average financial health and profitability rating. ABO is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

ABO had positive earnings in the past year.
In the past year ABO had a positive cash flow from operations.
ABO had positive earnings in each of the past 5 years.
ABO had a positive operating cash flow in each of the past 5 years.
ABO.BR Yearly Net Income VS EBIT VS OCF VS FCFABO.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

1.2 Ratios

ABO's Return On Assets of 1.93% is in line compared to the rest of the industry. ABO outperforms 50.00% of its industry peers.
ABO has a Return On Equity of 7.34%. This is comparable to the rest of the industry: ABO outperforms 50.00% of its industry peers.
With a decent Return On Invested Capital value of 6.90%, ABO is doing good in the industry, outperforming 73.81% of the companies in the same industry.
ABO had an Average Return On Invested Capital over the past 3 years of 6.75%. This is in line with the industry average of 7.31%.
The 3 year average ROIC (6.75%) for ABO is below the current ROIC(6.90%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.93%
ROE 7.34%
ROIC 6.9%
ROA(3y)2.67%
ROA(5y)2.95%
ROE(3y)9.24%
ROE(5y)10%
ROIC(3y)6.75%
ROIC(5y)6.66%
ABO.BR Yearly ROA, ROE, ROICABO.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

The Profit Margin of ABO (1.98%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of ABO has declined.
Looking at the Operating Margin, with a value of 5.11%, ABO is in line with its industry, outperforming 57.14% of the companies in the same industry.
In the last couple of years the Operating Margin of ABO has declined.
ABO's Gross Margin of 82.71% is amongst the best of the industry. ABO outperforms 83.33% of its industry peers.
ABO's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.11%
PM (TTM) 1.98%
GM 82.71%
OM growth 3Y6%
OM growth 5Y-3.01%
PM growth 3Y-14.39%
PM growth 5Y-11.63%
GM growth 3Y-2.08%
GM growth 5Y-1.79%
ABO.BR Yearly Profit, Operating, Gross MarginsABO.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ABO is creating some value.
Compared to 1 year ago, ABO has about the same amount of shares outstanding.
ABO has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for ABO is higher compared to a year ago.
ABO.BR Yearly Shares OutstandingABO.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ABO.BR Yearly Total Debt VS Total AssetsABO.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

ABO has an Altman-Z score of 2.07. This is not the best score and indicates that ABO is in the grey zone with still only limited risk for bankruptcy at the moment.
ABO has a better Altman-Z score (2.07) than 64.29% of its industry peers.
The Debt to FCF ratio of ABO is 12.48, which is on the high side as it means it would take ABO, 12.48 years of fcf income to pay off all of its debts.
ABO has a Debt to FCF ratio of 12.48. This is comparable to the rest of the industry: ABO outperforms 54.76% of its industry peers.
ABO has a Debt/Equity ratio of 0.63. This is a neutral value indicating ABO is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.63, ABO is doing good in the industry, outperforming 61.90% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 12.48
Altman-Z 2.07
ROIC/WACC1.13
WACC6.1%
ABO.BR Yearly LT Debt VS Equity VS FCFABO.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.3 Liquidity

ABO has a Current Ratio of 1.09. This is a normal value and indicates that ABO is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ABO (1.09) is worse than 64.29% of its industry peers.
ABO has a Quick Ratio of 1.06. This is a normal value and indicates that ABO is financially healthy and should not expect problems in meeting its short term obligations.
ABO has a Quick ratio (1.06) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.06
ABO.BR Yearly Current Assets VS Current LiabilitesABO.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for ABO have decreased strongly by -24.90% in the last year.
ABO shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.48% yearly.
The Revenue has grown by 14.63% in the past year. This is quite good.
ABO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.83% yearly.
EPS 1Y (TTM)-24.9%
EPS 3Y-1.79%
EPS 5Y1.48%
EPS Q2Q%-22.64%
Revenue 1Y (TTM)14.63%
Revenue growth 3Y14.71%
Revenue growth 5Y14.83%
Sales Q2Q%14.96%

3.2 Future

Based on estimates for the next years, ABO will show a decrease in Earnings Per Share. The EPS will decrease by -0.46% on average per year.
The Revenue is expected to grow by 14.99% on average over the next years. This is quite good.
EPS Next YN/A
EPS Next 2Y5.71%
EPS Next 3Y-0.46%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2Y23.53%
Revenue Next 3Y14.99%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ABO.BR Yearly Revenue VS EstimatesABO.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 2027 20M 40M 60M 80M 100M
ABO.BR Yearly EPS VS EstimatesABO.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2026 2027 0.1 0.2 0.3 0.4 0.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 34.72, which means the current valuation is very expensive for ABO.
ABO's Price/Earnings is on the same level as the industry average.
ABO's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.50.
Industry RankSector Rank
PE 34.72
Fwd PE N/A
ABO.BR Price Earnings VS Forward Price EarningsABO.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ABO indicates a somewhat cheap valuation: ABO is cheaper than 64.29% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABO is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 21.62
EV/EBITDA 7.21
ABO.BR Per share dataABO.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)23.49
EPS Next 2Y5.71%
EPS Next 3Y-0.46%

More info and screens

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.55%, ABO has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 4.10, ABO has a dividend in line with its industry peers.
ABO's Dividend Yield is slightly below the S&P500 average, which is at 2.35.
Industry RankSector Rank
Dividend Yield 1.55%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y5.71%
EPS Next 3Y-0.46%
ABO.BR Yearly Income VS Free CF VS DividendABO.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

ABO GROUP ENVIRONMENT

EBR:ABO (7/18/2025, 7:00:00 PM)

6.25

-0.05 (-0.79%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.28%
Inst Owner ChangeN/A
Ins Owners85.24%
Ins Owner ChangeN/A
Market Cap66.06M
Analysts84
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.55%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 34.72
Fwd PE N/A
P/S 0.69
P/FCF 21.62
P/OCF 8.52
P/B 2.56
P/tB 4.38
EV/EBITDA 7.21
EPS(TTM)0.18
EY2.88%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.29
FCFY4.62%
OCF(TTM)0.73
OCFY11.74%
SpS9.07
BVpS2.44
TBVpS1.43
PEG (NY)N/A
PEG (5Y)23.49
Profitability
Industry RankSector Rank
ROA 1.93%
ROE 7.34%
ROCE 9.97%
ROIC 6.9%
ROICexc 9.5%
ROICexgc 13.6%
OM 5.11%
PM (TTM) 1.98%
GM 82.71%
FCFM 3.19%
ROA(3y)2.67%
ROA(5y)2.95%
ROE(3y)9.24%
ROE(5y)10%
ROIC(3y)6.75%
ROIC(5y)6.66%
ROICexc(3y)10.47%
ROICexc(5y)11.44%
ROICexgc(3y)13.66%
ROICexgc(5y)14.41%
ROCE(3y)9.75%
ROCE(5y)9.61%
ROICexcg growth 3Y3.29%
ROICexcg growth 5Y5.77%
ROICexc growth 3Y-2.3%
ROICexc growth 5Y0.98%
OM growth 3Y6%
OM growth 5Y-3.01%
PM growth 3Y-14.39%
PM growth 5Y-11.63%
GM growth 3Y-2.08%
GM growth 5Y-1.79%
F-Score6
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 12.48
Debt/EBITDA 1.29
Cap/Depr 60.56%
Cap/Sales 4.9%
Interest Coverage 3.48
Cash Conversion 61.27%
Profit Quality 161.04%
Current Ratio 1.09
Quick Ratio 1.06
Altman-Z 2.07
F-Score6
WACC6.1%
ROIC/WACC1.13
Cap/Depr(3y)61.35%
Cap/Depr(5y)64.84%
Cap/Sales(3y)4.92%
Cap/Sales(5y)5.25%
Profit Quality(3y)155.26%
Profit Quality(5y)177.18%
High Growth Momentum
Growth
EPS 1Y (TTM)-24.9%
EPS 3Y-1.79%
EPS 5Y1.48%
EPS Q2Q%-22.64%
EPS Next YN/A
EPS Next 2Y5.71%
EPS Next 3Y-0.46%
EPS Next 5YN/A
Revenue 1Y (TTM)14.63%
Revenue growth 3Y14.71%
Revenue growth 5Y14.83%
Sales Q2Q%14.96%
Revenue Next YearN/A
Revenue Next 2Y23.53%
Revenue Next 3Y14.99%
Revenue Next 5YN/A
EBIT growth 1Y4.44%
EBIT growth 3Y21.59%
EBIT growth 5Y11.37%
EBIT Next YearN/A
EBIT Next 3Y34.11%
EBIT Next 5YN/A
FCF growth 1Y-19.09%
FCF growth 3Y9.03%
FCF growth 5Y-6.88%
OCF growth 1Y0.65%
OCF growth 3Y4.61%
OCF growth 5Y4.02%